Bengaluru: For years, oral cancer in India has been viewed through the lens of male tobacco use, even though women in parts ...

The FDA has granted accelerated approval to sevabertinib (Hyrnuo) for the treatment of patients with locally advanced or metastatic, nonsquamous non–small cell lung cancer (NS-NSCLC) with HER2 ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

This discussion looks ahead at how the role of PD-1 inhibitors may continue to evolve in the treatment of esophageal squamous ...

This discussion provides a forward-looking discussion on how the role of PD-1 inhibitors may continue to evolve in the ...

Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW dose ...

Keytruda plus platinum-based chemotherapy was found to be both safe and efficacious in treating penile squamous cell carcinoma (PSCC), according to findings from the phase 2 HERCULES trial presented ...

Phase I clinical trials remain essential for new drug development, identifying new treatment pathways, and identifying optimal dosing, the American Society of Clinical Oncology emphasized in a new ...

On5, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or ...

Lung cancer begins when abnormal cells grow and multiply in an uncontrolled way in the lungs. Cancer that starts in the lungs is called primary lung ...

India’s Sun Pharmaceutical Industries today announced the US Food and Drug Administration (FDA) approved an updated label for ...